Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2008 Sep 30:6:105.
doi: 10.1186/1477-7819-6-105.

Segmental resection of the duodenum for gastrointestinal stromal tumor (GIST)

Affiliations
Case Reports

Segmental resection of the duodenum for gastrointestinal stromal tumor (GIST)

Rudolf Mennigen et al. World J Surg Oncol. .

Abstract

Background: Gastrointestinal stromal tumors (GIST) are the most frequent mesenchymal tumors of the gastrointestinal tract. The biological appearance of these tumors reaches from small lesions with benign appearance to aggressive sarcomas. Only 3-5% of GISTs are localized in the duodenum. There is a controversy, if duodenal GISTs should be treated by a duodenopancreatectomy or by a limited resection of the duodenum.

Case presentation: A 29-year-old man presented with an acute upper gastrointestinal bleeding from a submucosal tumor located in the proximal part III of the duodenum, 3 cm distal of the papilla of Vater. After an emergency laparotomy with ligation of tumor-feeding vessels in a primary hospital, definitive surgical therapy was performed by partial resection of the duodenum with a duodenojejunostomy. Histology revealed a GIST with a diameter of 2.5 cm and <5 mitoses/50 high power fields, indicating a low risk of malignancy. Therefore no adjuvant therapy with Imatinib was initiated.

Conclusion: GISTs of the duodenum are a rare cause of upper gastrointestinal bleeding. Partial resection of the duodenum is a warranted alternative to a duodenopancreatectomy, as this procedure has a lower operative morbidity, while providing comparable oncological results.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Computed tomography. The computed tomography showed an enhancing tumor of the duodenal wall (arrowheads) with a maximal diameter of 2.5 cm. No metastases were visualized.
Figure 2
Figure 2
Operative view. Exophytic tumor of the proximal third part of the duodenum (arrowhead).
Figure 3
Figure 3
Operative technique. Reconstruction by a lateroterminal duodenojejunostomy at the level of the ampulla of Vater. P: pancreas, V: ampulla of Vater, T: tumor, J: jejunum.
Figure 4
Figure 4
Macroscopic appearance of the resected specimen. The distance to the proximal resection margin was 0.5 cm. A great portion of the tumor was located subserosal. The duodenal mucosa was bulged by the sumucosal tumor.
Figure 5
Figure 5
Histology. Microscopic appearance of the GIST located in the submucosa of the duodenum (left; H&E, original magnification ×10). It consists of small spindle-like tumor cells (middle; H&E, original magnification ×20) with CD117 – positivity (right; original magnification ×10).

References

    1. Joensuu H. Gastrointestinal stromal tumor (GIST) Ann Oncol. 2006;17:280–286. doi: 10.1093/annonc/mdl274. - DOI - PubMed
    1. Miettinen M, Kopczynski J, Makhlouf HR, Sarlomo-Rikala M, Gyorffy H, Burke A, Sobin LH, Lasota J. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol. 2003;27:625–641. doi: 10.1097/00000478-200305000-00006. - DOI - PubMed
    1. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279:577–580. doi: 10.1126/science.279.5350.577. - DOI - PubMed
    1. Goettsch WG, Bos SD, Breekveldt-Postma N, Casparie M, Herings RM, Hogendoorn PC. Incidence of gastrointestinal stromal tumours is underestimated: results of a nation-wide study. Eur J Cancer. 2005;41:2868–2872. doi: 10.1016/j.ejca.2005.09.009. - DOI - PubMed
    1. Nilsson B, Bümming P, Meis-Kindblom JM, Odén A, Dortok A, Gustavsson B, Sablinska K, Kindblom LG. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era – a population-based study in western Sweden. Cancer. 2005;103:821–829. doi: 10.1002/cncr.20862. - DOI - PubMed

Publication types